Generous donors keep CHEO equipped with cutting-edge technology. Far from being a luxury, these devices modernize treatment for patients, delivering better results often with less stress. That is certainly the case with the new Fibroscan, a device purchased with the help of community funds, which can detect and measure fibrosis (scarring) and hardness in the tissue of the liver. Before acquiring the Fibroscan, this required a biopsy or exploratory surgery.
Now, a patient’s liver can be scanned in 10 minutes in the most minimally invasive way. This reduces stress on the patient, and there is no recovery period needed. Inpatients can be tested at their bedside, and those coming into CHEO for testing spend minimal time in the hospital. For patients with cystic fibrosis, kidney or liver disease and others, this is an enormous improvement in treatment and care. Your support helps CHEO make vital equipment purchases and important facility upgrades.